Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Oxysterols as biomarkers in neurodegenerative diseases.

Leoni V, Caccia C.

Chem Phys Lipids. 2011 Sep;164(6):515-24. doi: 10.1016/j.chemphyslip.2011.04.002. Epub 2011 Apr 16. Review.

PMID:
21515244
2.

Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid.

Leoni V, Caccia C.

Biochem Pharmacol. 2013 Jul 1;86(1):26-36. doi: 10.1016/j.bcp.2013.03.015. Epub 2013 Mar 28. Review.

PMID:
23541982
3.

Links between ApoE, brain cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive impairment.

Leoni V, Solomon A, Kivipelto M.

Biochem Soc Trans. 2010 Aug;38(4):1021-5. doi: 10.1042/BST0381021. Review.

PMID:
20658997
4.

Oxysterols as markers of neurological disease--a review.

Leoni V.

Scand J Clin Lab Invest. 2009;69(1):22-5. doi: 10.1080/00365510802651858. Review.

PMID:
19199127
5.

24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases.

Leoni V, Caccia C.

Biochimie. 2013 Mar;95(3):595-612. doi: 10.1016/j.biochi.2012.09.025. Epub 2012 Oct 3. Review.

PMID:
23041502
6.

24S-hydroxycholesterol: a marker of brain cholesterol metabolism.

Lütjohann D, von Bergmann K.

Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S102-6.

PMID:
14574622
7.

Diagnostic use of cerebral and extracerebral oxysterols.

Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Björkhem I.

Clin Chem Lab Med. 2004 Feb;42(2):186-91.

PMID:
15061359
8.

Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?

Leoni V, Shafaati M, Salomon A, Kivipelto M, Björkhem I, Wahlund LO.

Neurosci Lett. 2006 Apr 10-17;397(1-2):83-7. Epub 2006 Jan 6.

PMID:
16406316
9.

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.

Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Björkhem I, von Bergmann K, Heun R.

J Psychiatr Res. 2002 Jan-Feb;36(1):27-32.

PMID:
11755458
10.

Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.

Solomon A, Leoni V, Kivipelto M, Besga A, Oksengård AR, Julin P, Svensson L, Wahlund LO, Andreasen N, Winblad B, Soininen H, Björkhem I.

Neurosci Lett. 2009 Oct 2;462(1):89-93. doi: 10.1016/j.neulet.2009.06.073. Epub 2009 Jun 26.

PMID:
19560513
11.

Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.

Novakova L, Axelsson M, Malmeström C, Zetterberg H, Björkhem I, Karrenbauer VD, Lycke J.

J Neurol Sci. 2015 Nov 15;358(1-2):201-6. doi: 10.1016/j.jns.2015.08.1537. Epub 2015 Aug 29.

PMID:
26342940
12.

24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome.

Björkhem I, Patra K, Boxer AL, Svenningsson P.

Front Neurol. 2018 Sep 7;9:756. doi: 10.3389/fneur.2018.00756. eCollection 2018.

13.

Sulphatation does not appear to be a protective mechanism to prevent oxysterol accumulation in humans and mice.

Acimovic J, Lövgren-Sandblom A, Olin M, Ali Z, Heverin M, Schüle R, Schöls L, Fischler B, Fickert P, Trauner M, Björkhem I.

PLoS One. 2013 Jul 3;8(7):e68031. doi: 10.1371/journal.pone.0068031. Print 2013.

14.

Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.

Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL.

Eur Arch Psychiatry Clin Neurosci. 2018 Aug;268(5):501-507. doi: 10.1007/s00406-017-0838-2. Epub 2017 Aug 31.

PMID:
28861608
15.

Oxysterols and neurodegenerative diseases.

Björkhem I, Cedazo-Minguez A, Leoni V, Meaney S.

Mol Aspects Med. 2009 Jun;30(3):171-9. doi: 10.1016/j.mam.2009.02.001. Epub 2009 Feb 25. Review.

PMID:
19248803
16.

Brain lipoprotein metabolism and its relation to neurodegenerative disease.

Danik M, Champagne D, Petit-Turcotte C, Beffert U, Poirier J.

Crit Rev Neurobiol. 1999;13(4):357-407. Review.

PMID:
11028681
17.

Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease.

Popp J, Meichsner S, Kölsch H, Lewczuk P, Maier W, Kornhuber J, Jessen F, Lütjohann D.

Biochem Pharmacol. 2013 Jul 1;86(1):37-42. doi: 10.1016/j.bcp.2012.12.007. Epub 2013 Jan 3.

PMID:
23291240
18.

Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.

Shafaati M, Solomon A, Kivipelto M, Björkhem I, Leoni V.

Neurosci Lett. 2007 Sep 25;425(2):78-82. Epub 2007 Aug 15.

PMID:
17822846
19.

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.

Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R.

J Lipid Res. 2000 Feb;41(2):195-8.

20.

Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.

van de Kraats C, Killestein J, Popescu V, Rijkers E, Vrenken H, Lütjohann D, Barkhof F, Polman CH, Teunissen CE.

Mult Scler. 2014 Apr;20(4):412-7. doi: 10.1177/1352458513499421. Epub 2013 Aug 19.

PMID:
23959711

Supplemental Content

Support Center